IBM looks like a long-term buy with record long-term accumulation behind it. Its last candle showed $245B of six-month high-volume accumulation, and the stock is retesting both EMAs and $232.90 support. A $14M write of long-dated $300 calls reads as a hedge by large holders who accumulated near $300, not a bearish bet; a retest of $300 is the next test, with $200 the level that would invalidate it. x.com 

IBM looks attractive because investors are treating a timing slip like a demand collapse. x.com 

IBM is a valuation trap, with a high-conviction sell target of $200 by December 2026 as its multiple compresses toward its historical average. It lags in AI and quantum, its premium P/E lacks the structural growth to justify it, and its CY26 EPS estimate of $12.35 is under threat. A macro slowdown could push enterprises to cut nice-to-have transformation projects, and missing hyped quantum milestones would speed a rerating as Google and Microsoft pull ahead. x.com  x.com 

IBM stands to benefit from massive quantum investment: the Trump administration is awarding $2 billion in grants to nine quantum-computing companies, and IBM is getting $1 billion of it. The chart also shows support, with a tweezer bottom, a Friday push above the 200 EMA and a volume gap above. x.com 

IBM has a quantum catalyst in a $10B five-year commitment and a big US government deal, plus AI and hybrid cloud tailwinds as watsonx and generative AI bookings run strong and enterprise automation accelerates. The stock is almost above its 200-day moving average with momentum increasing. Analysts have issued multiple buy upgrades, including DZ Bank at $295, with targets of $280-$340+, 12-30% above roughly $255, and earnings estimates are rising. x.com 

IBM remains bearish on trend heading into earnings, which will be a damage report rather than a preview. It already pre-warned on July 15 with preliminary results well below estimates, BofA cut its target to $280, and the stock is down about 34%. Because much of the bad news is already out, a bounce is possible if it resets the bar and stops the bleeding. x.com 

IBM's fundamentals are catching up with its chart after the market panicked over July earnings, setting up a potential gap fill. Since then IBM secured a $240M Nvidia-powered cluster deal with Together AI, partnered with OpenAI and bought DataStax. The stock has recovered from its $199 low and is testing heavy resistance at $241 near its 50-day EMA; a break and hold above $242 would leave the gap above wide open. x.com 

IBM, the quantum computing leader, is a buy after President Trump fast-tracked quantum computing with multiple executive orders, making the next three years especially interesting for the company. x.com 

IBM is not a growth stock but a mature business held mostly for dividends, so it does not suit investors still in accumulation mode, as most on X are. x.com 

IBM's record one-day drop, on pace to surpass its 1987 Black Monday decline, is the biggest overreaction since Netflix's near-40% plunge in 2022. IBM's CEO said only a few large capex deals in mainframe and its associated software were paused near quarter-end, not a widespread problem, and that IBM does not see its software being disrupted by AI at all. x.com  x.com